Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 113,288 | 14,745 | 622 | 240 | 934 |
| Cost of Goods | 753 | N/A | N/A | N/A | N/A |
| Gross Profit | 112,535 | 14,745 | 622 | 240 | 934 |
| Operating Expenses | 369,315 | 358,927 | 362,872 | 351,538 | 331,214 |
| Operating Income | -256,027 | -344,182 | -362,250 | -351,298 | -330,280 |
| Interest Expense | 112,525 | 154,327 | 129,198 | 63,515 | 14,849 |
| Other Income | 16,945 | 84,864 | -92,444 | -2,473 | -4,710 |
| Pre-tax Income | -351,607 | -413,645 | -583,892 | -417,286 | -349,839 |
| Income Tax | -135 | N/A | -40 | 34 | 9 |
| Net Income Continuous | -351,472 | -413,645 | -583,852 | -417,320 | -349,848 |
| Minority Interests | -74 | -81 | -656 | -753 | -3,058 |
| Net Income | $-351,398 | $-413,564 | $-583,196 | $-416,567 | $-346,790 |
| EPS Basic Total Ops | -0.38 | -0.59 | -1.15 | -1.04 | -0.89 |
| EPS Basic Continuous Ops | -0.38 | -0.59 | -1.15 | -1.04 | -0.90 |
| EPS Diluted Total Ops | -0.38 | -0.62 | -1.15 | -1.04 | -0.89 |
| EPS Diluted Continuous Ops | -0.38 | -0.59 | -1.15 | -1.04 | -0.90 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.73 | -0.99 | N/A | N/A |
| EBITDA(a) | $-240,502 | $-304,041 | $-300,456 | $-315,438 | $-315,577 |